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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).SUMMARYRetinal progenitors are initially found in the anterior neural plate region known as the eye field, whereas neighboring areas undertake
telencephalic or hypothalamic development. Eye field cells become specified by switching on a network of eye field transcription factors,
but the extracellular cues activating this network remain unclear. In this study, we used chemically defined media to induce in vitro dif-
ferentiation of mouse embryonic stem cells (ESCs) toward eye field fates. Inhibition of Wnt/b-catenin signaling was sufficient to drive
ESCs to telencephalic, but not retinal, fates. Instead, retinal progenitors could be generated from competent differentiating mouse
ESCs by activation of Activin/Nodal signaling within a narrow temporal window corresponding to the emergence of primitive anterior
neural progenitors. Activin also promoted eye field gene expression in differentiating human ESCs. Our results reveal insights into the
mechanisms of eye field specification and open new avenues toward the generation of retinal progenitors for translational medicine.INTRODUCTION
The vertebrate retina originates from the eye field, an ante-
rior neural plate region identified by coexpression of a
network of eye field transcription factors (EFTFs) including,
among others, Rax and Pax6 (Viczian, 2013).
In vertebrate embryos, downregulation of the bone
morphogenetic protein (BMP) and Activin/Nodal signaling
pathways is responsible for the specification of forebrain
progenitors (Andoniadou and Martinez-Barbera, 2013).
Anterior-posterior gradients ofWnts, fibroblast growth fac-
tors, and retinoic acid impose diencephalic, midbrain,
hindbrain, or spinal cord identities on posteriorly located
neural precursors. Rostral forebrain fates, instead, are pre-
served in anterior regions by shielding them from these sig-
nals (Andoniadou andMartinez-Barbera, 2013;Wilson and
Houart, 2004).
Although diversification of the secondary prosenceph-
alon into telencephalon, eye field, and hypothalamus has
been difficult to dissect in vivo, it can be modeled in vitro
using mouse and human embryonic stem cells (mESCs
and hESCs, respectively). In these culture systems, both
endogenous and exogenous signals contribute to cell-fate532 Stem Cell Reports j Vol. 5 j 532–545 j October 13, 2015 j ª2015 The Aspecification. Previous reports have shown induction of
hypothalamic fates by minimizing ESC exposure to exoge-
nous signals (Wataya et al., 2008), whereas culture in min-
imal media in the presence of transforming growth factor b
andWnt pathway inhibitors causes telencephalic specifica-
tion (Bertacchi et al., 2015; Lupo et al., 2014). Extracellular
cues, instead, appear to be critical for the induction of eye
field fates, because production of retinal progenitors was
generally inefficient in ESC systems with reduced extracel-
lular signaling (Lupo et al., 2014).
Previous studies suggested that Activin/Nodal signaling
promotes eye field fates, as shown by enhanced retinal pro-
genitor generation inmESCs treatedwithexogenousActivin
(Ikeda et al., 2005) andby repression of eye field gene expres-
sion in hESCs differentiating in the presence of Activin/
Nodal pathway inhibitors (Lupo et al., 2013). The contribu-
tion of Activin/Nodal signaling to eye field specification,
however, remains poorly understood (Lupo et al., 2014; Vic-
zian, 2013). Here, building on previous studies (Ikeda et al.,
2005; Lupo et al., 2013), we provide much more extensive
evidence that Activin supports retinal identity in ESCs.
Notably, we show that this function is restricted to a narrow
time window coincident with the emergence of earlyuthors
forebrain progenitors from pluripotent cells. These findings
suggest the feasibility of efficiently mimicking retinal pro-
genitor formation in vitro using purely defined reagents.RESULTS
Activin Supports Expression of Eye Field Genes in
mESCs Differentiating to Anterior Neural Progenitors
We recently described a protocol of mESC neuralization
using a chemically defined minimal medium (CDMM)
(Bertacchi et al., 2013). mESCs are prompted to differen-
tiate by floating aggregate culture (step I, 2 days) and
then allowed to spontaneously neuralize as adherent cul-
tures (step II, 4–6 days). In these conditions, mESCs effi-
ciently convert to neural progenitors, which can undergo
neuronal differentiation following long-term culture (Ber-
tacchi et al., 2013, 2015).
With this protocol, we found that the endogenous levels
of extracellular signaling pathways in early differentiating
mESCs are permissive for neural conversion. Emerging
neural progenitors, however, produce BMP and Wnt sig-
nals that repress rostral forebrain specification and pro-
mote caudal forebrain/midbrain fates (Bertacchi et al.,
2013, 2015). Because BMP-dependent caudalization is, at
least in part, indirectly due to activation of Wnt signaling,
treatments withWnt/b-catenin inhibitors during step II are
sufficient to elicit rostral forebrain character in mESCs (Fig-
ures 1A–1C; Bertacchi et al., 2015). In this study, we used
this experimental system and a Rax-GFP knockin mESC
line (K/l EB5), driving eGFP expression under control of
the Rax promoter (Wataya et al., 2008), to investigate the
signals promoting eye field fates in early anterior neural
progenitors. mESCs were differentiated to neuroectoderm
with or without the Wnt/b-catenin signaling inhibitor
IWR-1-Endo (Wnti) applied from 3 days of in vitro differen-
tiation (3 DIV) (Figure 1A). Cells were harvested every 12 hr
between 3.5 and 10 DIV, and GFP-positive cells were de-
tected by flow cytometry or immunostaining. Cells treated
withWnti showed a transient activation of GFP expression
between 5 and 6DIV (Figures 1B and 1D). GFP-positive cells
then decreased, reaching the very low numbers seen in
control cultures by 8 DIV (Figures 1B and 1E). By quantita-
tive RT-PCR (qRT-PCR), a peak of eye field marker (Rax,
Six6) transcription was detectable at 5 DIV, but it rapidly
declined (Figure 1C). Instead, telencephalic markers
(Emx2, FoxG1, Tbr1, Ctip2) were steadily upregulated
from 5 DIV onward (Figure 1C). Thus, differentiation in
the presence of Wnt/b-catenin inhibitors converts mESCs
to early forebrain progenitors that are competent to express
both eye field and telencephalic genes. In the absence of
appropriate signals, however, eye field gene transcription
is not maintained and telencephalic fates prevail.Stem CellPrevious work described repression of eye field genes in
adherent hESC cultures differentiating in the presence of
inhibitors of Activin/Nodal signaling (Lupo et al., 2013).
Furthermore, exogenous Activin enhances generation of
retinal progenitors inmESCs cultured as floating aggregates
in serum-containing media (Ikeda et al., 2005). Notably,
bioinformatic analysis of chromatin immunoprecipitation
sequencing datasets obtained in mouse and human ESCs
indicate that both SMAD2/3 and FOXH1, key components
of the Activin/Nodal pathway (Yamamoto et al., 2001), can
bind to a highly conserved region located within 2 kb up-
stream of the Rax transcription start site (Figure S1; Kim
et al., 2011; Mullen et al., 2011). Thus, the instability of
eye field gene transcription in our differentiation system
may be due to insufficient activation of Activin/Nodal
signaling.
mESCs differentiating to neuroectoderm with our proto-
col show very low expression of Activin/Nodal ligands, sug-
gesting that Activin/Nodal signaling remains quiescent in
these conditions (Bertacchi et al., 2015). Confirming these
data, we found that FoxH1 was barely expressed in either
control differentiation conditions or in the presence of
Wnti and/or the BMP pathway inhibitor dorsomorphin
(BMPi) at 6 DIV but was upregulated by treatments with
exogenous Activin (10–100 ng/ml; Figures S2A and S2B).
In these assays, weaker upregulation of FoxH1 in the pres-
ence of BMPi (Figure S2B) is likely due to the previously
described partial interference of BMPi with the Activin/
Nodal pathway (Zhou et al., 2010). As previously described
(Besser, 2004), high doses of Activin (50–100 ng/ml) also
upregulated Lefty1/2, which encode for feedback inhibitors
of Activin/Nodal signaling (Meno et al., 1999; Perea-
Gomez et al., 2002), whereas genes encoding for other
antagonists of this pathway (Fst; Hemmati-Brivanlou
et al., 1994) were not affected (Figure S3B).
In support of the idea that Activin/Nodal signaling needs
to be active for stable eye field gene transcription, simulta-
neous delivery of both Activin (10 ng/ml) andWnti during
mESC forebrain differentiation (Figure 1A; Figure S1C)
increased the fraction of Rax-GFP-positive cells at 8–10
DIV compared to cultures treated with Wnti alone (Figures
1B and 1D–1F). Costaining with PAX6 suggested that Rax-
GFP-positive cells had a retinal progenitor identity (Figures
1G and 1G0). By qRT-PCR at 8 DIV, cultures treated
with both Activin and Wnti showed upregulation of eye
field markers (Otx2, Six3, Rax, Six6, Tbx3, Vsx2) and
downregulation of telencephalic markers (FoxG1, Emx2,
Tbr1, Ctip2) in comparison with Wnti-treated samples
(Figure 1H).
In time course assays, the percentage of Rax-GFP-positive
cells in Activin-treated cultures, compared to samples
treated with Wnti only, was lower at 5–6 DIV and became
similar at 6.5 DIV (Figure 1B). From 6.5 DIV, however,Reports j Vol. 5 j 532–545 j October 13, 2015 j ª2015 The Authors 533
Figure 1. Activin Supports Rax Expression in mESC-Derived Early Anterior Neural Progenitors
(A) Scheme of mESC neuroectoderm differentiation with or without Wnti and Activin. Days show the time of mouse ESC differentiation after
LIF (LIF) and serum withdrawal.
(B) Flow cytometry of K/l EB5 cells harvested at different time points showing the percentage of Rax-GFP-positive cells during differ-
entiation in plain CDMM (control) or in the presence of Wnti or Wnti and Activin (Wnti+Act), as indicated. Error bars represent SEM (n = 4
independent experiments with n = 3 in vitro technical replicates per experiment; technical replicates were pooled together and analyzed by
n = 3 flow cytometry acquisitions).
(C) qRT-PCR quantification of telencephalic (Emx2, FoxG1, Tbr1, Ctip2) and eye field (Rax, Six6) gene expression in cells differentiated in
the presence of Wnti and harvested every 24 hr between 4 and 8 DIV. For each analyzed gene, the sample with maximal transcription levels
was chosen for normalization, and relative expression levels in all the other samples are shown. Error bars were obtained from the error
propagation formula (n = 3 independent biological replicates were pooled together and analyzed by qRT-PCR).
(D–F) GFP immunodetection of cells differentiated in the presence of Wnti or Wnti and Activin (Wnti/Act.). The scale bars represent 50 mm.
Dapi, 40,6-diamidino-2-phenylindole.
(G and G0) Double immunodetection at 8 DIV in cultures treated with Wnti and Activin. The scale bar represents 10 mm.
(H) qRT-PCR of mesencephalic (En1, Otx2), telencephalic (Emx2, FoxG1, Ctip2, Tbr1), and eye field (Rax, Six6, Vsx2, Six3, Otx2, Tbx3) marker
expression at 8 DIV in cultures differentiated in control medium (CDMM) or in medium supplemented with Wnti (Wnti) or both Wnti and
Activin (10 ng/ml; Wnti+Act). Error bars were obtained from the error propagation formula (n = 3 independent experiments were pooled
together and analyzed by qRT-PCR; each experiment contained n = 2 in vitro technical replicates).
See also Figures S1 and S2.
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Rax-GFP-positive cells rapidly disappeared in Wnti-treated
cultures, whereas their fraction progressively increased in
the presence of Activin, nearly reaching 50% at 10DIV (Fig-
ure 1B). Activin treatment delayed mESC neuralization, as
shown by enhanced expression of the epiblast markers
Oct4 and Fgf5 and repression of the neuroectodermmarkers
Pax6 and NCAM at 6 DIV compared to controls (Fig-
ure S2D), thus explaining the later appearance of Rax-
GFP-positive cells in Activin-treated cultures. Nonetheless,
Oct4 and Fgf5 were downregulated at 8 DIV (Figure S2D)
and neural progenitors expressing Rax-GFP, Pax6, and
other eye field markers (e.g., Six3, Six6, Tbx3) became
evident (Figures S2E–S2H). Thus, low doses of Activin can
transiently delay neural differentiation in mESCs but,
once cells convert to neural progenitors, Activin signaling
can steer them toward eye field fates.
We systematically analyzed the effects of Activin/Nodal
signaling on neural induction and patterning in mESCs,
starting by treating differentiating cells with exogenous
Activin at different concentrations. We delivered Activin
and Wnti simultaneously from 3 DIV using 10, 50, and
100 ng/ml Activin (Figure S3). Activin caused dose-depen-
dent inhibition of neural progenitor markers (Sox2, Nestin,
Pax6, Musashi) and upregulation of pluripotency (Oct4,
Fgf5) and mesendoderm (Gata4, Gata6) markers at 6 DIV
(Figures S3B–S3L). The ability of Activin to upregulate
expression of eye field markers (Otx2, Six3, Rax, Six6,
Vsx2, Tbx3) decreased at higher doses, consistent with a
stronger inhibition of neural differentiation (Figure S3M),
whereas transcription of the telencephalic markers Foxg1
and Emx2was always repressed (Figure S3M). Activin deliv-
ery in the absence of Wnti caused a stronger upregulation
of mesendoderm markers (Figure S3B) and a weaker upre-
gulation of eye field markers (Figure S3M) in comparison
with treatments with both Wnti and Activin, suggesting
that Activin elicits eye field fates specifically in anterior
neural progenitors, which form more efficiently when
the Wnt/b-catenin pathway is inhibited (Bertacchi et al.,
2015). The effects of Activin in the presence of both
Wnti and BMPi were similar to those of treatments
without BMPi (Figures S3B–S3M), indicating that endoge-
nous BMP signaling does not hinder eye field specification
in this system. Treatments with the Activin/Nodal inhibi-
tor SB431542 did not affect expression of eye field or telen-
cephalic markers (Figure S3N), in agreement with the very
low endogenous activation of Activin/Nodal signaling in
these conditions (Bertacchi et al., 2015). Although these
data suggest that Activin can steer pluripotent stem cells
differentiating to anterior neuroectoderm toward eye field
fates, their interpretation is complicated by the fact that
early Activin treatments, in line with previous studies
(Lupo et al., 2014; Vallier et al., 2004), interfere with
mESC neuralization.Stem CellActivin Promotes Eye Field Fates within a Specific
Time Window during Differentiation of mESCs to
Anterior Neural Progenitors
To distinguish an earlier role of Activin/Nodal signaling in
opposing neuroectoderm differentiation from a later role
in anterior neural patterning, we focused on a moderate
dose of Activin (10 ng/ml), which is more permissive to-
ward mESC neuralization compared to higher doses (Fig-
ures S2C and S3), but started the treatments at different
time points during anterior neural differentiation. Cultures
were treatedwithWnti from3DIVwith or without Activin,
which was added starting at the same time point or with
increasing delays of 12, 24, 36, or 48 hr (Figure 2A); the per-
centage of the total cell count that was positive for Rax-GFP
or OCT4 was then analyzed at 8 DIV. Cultures treated with
Wnti alone differentiated efficiently to neuroectoderm (as
shown by very few OCT4-positive cells), but they were re-
fractory to eye field specification (5% Rax-GFP-positive
cells; Figures 2B and 2C).When Activin was added together
with Wnti (3 DIV), it promoted eye field specification
(26.9%of Rax-GFP-positive cells; Figures 2B and 2D) but de-
layed neuroectoderm differentiation (18.9% of OCT4-pos-
itive cells persisting at 8 DIV; Figures 2B and 2D). Delaying
the start of Activin treatment by 12–36 hr after Wnti deliv-
ery (3.5–4.5 DIV; Figure 2A) nearly doubled the percentage
of Rax-GFP-positive cells (up to 45.2% Rax-GFP-positive
cells at 8 DIV; Figures 2B–2G) without delaying differentia-
tion (3% OCT4-positive cells at 8 DIV following Activin
treatment from 4 DIV; Figures 2B–2G). No induction of
Rax-GFP-positive cells was observed when cultures were
treated with Activin starting from 5 DIV (5.5% Rax-GFP-
positive cells at 8 DIV; Figures 2B and 2H). qRT-PCR ana-
lyses confirmed that transcription of Six3, Rax, Six6, and
Vsx2 peakedwhenActivin treatmentswere started between
12 and 36 hr after Wnti delivery (Figure 2I) but was similar
to control (Wnt inhibition alone) levels when applying
Activin 48 hr after Wnti (Figure 2I).
Activin treatment conditions causing optimal upregula-
tion of eye field genes were also more effective at downre-
gulating expression of telencephalic markers (Figure 2I).
Activin efficiently enhanced eye field gene expression
only in cultures treated withWnti (Figures 2B and 2I), sup-
porting the idea that Activin promotes eye field fates in
anterior neural progenitors.
Higher Activin doses (50 ng/ml), even when delivered at
3.5 DIV (Figure S4A), decreased the fraction of Rax-GFP-
positive cells at 8 DIV, probably due to maintenance of
Oct4 expression and delayed neuroectoderm differentia-
tion (Figures S4B–S4M). Altogether, these results suggest
that Activin plays different roles at different stages of
mESC differentiation. At early stages (up to 3 DIV), Activin
opposes neuroectoderm specification by promoting
expression of pluripotency and mesendoderm genes. InReports j Vol. 5 j 532–545 j October 13, 2015 j ª2015 The Authors 535
Figure 2. Activin Promotes Rax Expression within a Restricted Time Window during mESC Differentiation to Anterior
Neuroectoderm
(A) Scheme of temporally controlled Activin treatments.
(B) Percentage of the total K/l EB5 cell count that was positive for OCT4 or Rax-GFP. Culture conditions were as in (A). Ctrl, control (CDMM).
Error bars represent SEM (n = 3 independent experiments).
(C–H) Representative images of K/l EB5 cells differentiated in the conditions indicated in (A) and immunostained for both GFP and OCT4 at
8 DIV. The scale bars represent 50 mm.
(I) qRT-PCR of neuroectoderm (Pax6), telencephalic (Tbr1, Emx2, FoxG1), and eye field (Six3, Rax, Six6, Vsx2) gene expression in the
conditions indicated in (A). Values are normalized to samples with maximal expression levels. Error bars were obtained from the error
propagation formula (n = 3 independent experiments were pooled together; each experiment contained n = 2 technical replicates).
See also Figures S3 and S4.
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early anterior neural progenitors, which emerge at 3.5–4.5
DIV in conditions of low Wnt signaling, moderate Activin
levels promote eye field fates.
Activin Promotes Formation of Rax-Expressing
Progenitors Bearing Retinal-Specific Regional
Identities
In mouse embryos, strong Rax expression is found both in
the developing retina and ventral hypothalamus (Wataya
et al., 2008). Retinal progenitors express Rax and Pax6,
whereas ventral hypothalamic progenitors express Rax
and Nkx2.1 (Ikeda et al., 2005; Wilson and Houart, 2004).
Because Wnt inhibition and Activin/Nodal signaling have
been implicated in hypothalamic development (Kapsimali
et al., 2004; Mathieu et al., 2002), we investigated whether
Rax-expressing progenitors generated in the presence of
Wnti and Activin acquired retinal and/or hypothalamic
identities. Sonic Hedgehog (SHH) signaling has a well-
established role in promoting hypothalamic development
(Ikeda et al., 2005; Wataya et al., 2008). Therefore, to better
distinguish Rax-positive retinal fates from Rax-positive hy-
pothalamic fates, we compared the identity of Rax-express-
ing progenitors forming in Activin-treated cultures with
that of Rax-positive cells generated in cultures treated
with SHH pathway agonists.
Rax-GFP-positive progenitors induced by treating differ-
entiating mESC cultures with both Wnti (from 3 DIV)
and Activin (from 3.5 DIV) were mostly PAX6 positive
and NKX2.1 negative at 8 DIV (up to 40.7% Rax-GFP-posi-
tive cells, 32.4% Rax-GFP/PAX6 double-positive cells, 2.2%
Rax-GFP/NKX2.1 double-positive cells; Figure 3), suggest-
ing that they had acquired a retinal identity.
Previous studies indicated that activation of SHH
signaling in mESCs differentiating to anterior neuroecto-
derm led to the specification of ventral hypothalamic pro-
genitors expressing Rax and Nkx2.1 (Wataya et al., 2008).
To further confirm that Rax-positive cells generated in
Activin-treated cultures acquired a retinal, rather than hy-
pothalamic, identity, we generated Rax-positive ventral
forebrain progenitors by means of treatments with a
Smoothened agonist (SAG; 100 nM). SAG was added to
differentiating mESC cultures from 3 DIV with or without
Wnti. Some of these cultures were also treated with Activin
from 3.5 DIV (Figure 3A). SAG robustly increased the per-
centage of Rax-GFP-positive cells (up to 61.6% of the total
cell count) at 8 DIV, but only in cultures treated with
Wnti (Figures 3B–3D). In contrast to Activin treatments,
however, the vast majority of these cells were PAX6 nega-
tive and NKX2.1 positive (0.6% Rax-GFP/PAX6 double-
positive cells, 60% Rax-GFP/NKX2.1 double-positive cells;
Figures 3B and 3D), indicating acquisition of a ventral
hypothalamic identity. NKX2.1-expressing cells were
increased by SAG also in the absence of Wnti (65.3%Stem CellNKX2.1-positive cells), but they were mostly Rax-GFP
negative (Figures 3B and 3C). Activin and SAG treatments
together did not show collaborative effects in the
generation of Rax-GFP-positive cells, which were mostly
PAX6 negative and NKX2.1 positive (Figures 3B–3D).
Similar results were obtained when cultures were treated
with Activin and different doses of SAG (1, 10, 100 nM; Fig-
ures S5A–S5D). Inhibition of SHH signaling with cyclop-
amine (5 mM) in cultures treated with Activin did not
enhance either the generation of Rax-GFP-positive cells or
the fraction of cells coexpressing Rax-GFP and PAX6 (Fig-
ures 3B–3D), in agreement with the observation that
endogenous SHH signaling is inactive during the early
stages of our differentiation protocol (Bertacchi et al.,
2015).
Treatments withWnti and Activin could promote forma-
tion of Rax-GFP/PAX6-positive (NKX2.1-negative) retinal
progenitors even when cells were maintained as floating
aggregates until harvesting at 10 DIV (Figures S5E and
S5F). Treatments of floating aggregate cultures with Wnti
and SAG led to formation of Rax-GFP/NKX2.1-positive
(PAX6-negative) progenitors. Retinal progenitors were
mainly present within superficial layers of Activin-treated
cell aggregates, whereas hypothalamic progenitors could
be found throughout SAG-treated aggregates. This may
be explained by more limited diffusion of exogenous
signaling proteins (as compared to small molecules) within
cell aggregates.
We further characterized the positional identity of
adherent cultures treated with either Wnti and Activin or
Wnti and SAG by global transcriptomic analyses.We sorted
Rax-positive (Rax+) or Rax-negative (Rax) cells from these
cultures at 10 DIV (Figures S6A–S6E) and used them, along
with unsorted cells from cultures treated only with
Wnti, for microarray-based comparative gene expression
profiling with respect to eye, cortex, or hypothalamus/
diencephalon explanted from embryonic day 12.5 mouse
embryos (Figure 4; Figures S6F–S6H). Pearson correlation
analysis indicated that cell cultures and embryonic tissues
clustered separately, with high values of correlation among
samples of the same category (Figure S6F). Principal
component analysis (PCA) confirmed that cultures and tis-
sues formed well-separated groups (Figure S6G). Moreover,
it indicated that the large majority of genes whose ex-
pression varies among different samples (principal compo-
nent 1, accounting for 92.7% of variance) is actually not
separating them and that only a small ratio of gene expres-
sion variance (principal component 2, accounting for 2.2%
of variance) is responsible for the difference between cell-
culture sample and tissue sample groups (Figure S6G).
These analyses suggested that the genes whose expression
accounts for differences among different brain regions,
and different cell-culture conditions, are few, and that theReports j Vol. 5 j 532–545 j October 13, 2015 j ª2015 The Authors 537
Figure 3. Activin and SHH Signaling Promote Retinal Progenitor or Ventral Forebrain Progenitor Identity, Respectively, in mESCs
Differentiating to Anterior Neuroectoderm
(A) Scheme of anterior neural differentiation of mESCs in the presence of different signaling molecules. Activin was applied 12 hr after the
start of Wnti treatments, whereas SAG or cyclopamine (Cyc) was delivered simultaneously with Wnti.
(B) Quantification of the percentage of the total K/l EB5 cell count that was positive for Rax-GFP and/or PAX6 (left chart) or for Rax-GFP
and/or NKX2.1 (right chart), as detected by immunodetection at 8 DIV, following differentiation in the indicated conditions. Error bars
represent SEM (n = 3 independent experiments).
(C and D) Representative images of K/l EB5 cells differentiated in the indicated conditions at 8 DIV. The scale bars represent 30 mm.
See also Figure S5.variance of their expression is masked by the variance of
the rest of the genes. We then performed clustering and
PCA on a transcriptome subset, including genes with high-
est variance among tissues or cultures (see the Experi-
mental Procedures). Analysis of this subset indicated that
cells treated with Wnti and Activin clustered with embry-
onic eye tissue and cells treated with Wnti and SAG
clustered with embryonic hypothalamus/diencephalon,
whereas control cultures treated with Wnti only clustered
with embryonic cortex (Figures 4A and 4B). Notably, the538 Stem Cell Reports j Vol. 5 j 532–545 j October 13, 2015 j ª2015 The Avalues of correlation among samples of the same category
(cell culture or tissue) were quite low, indicating that this
subset of genes can discriminate different positional identi-
ties in both cell culture and tissue samples, regardless of
their in vitro or in vivo origin (Figure 4A). Accordingly,
the first two principal components of the PCA, together ac-
counting for 49.8% and 19.3% of variance, respectively,
divided the samples into the same threemajor clusters (cor-
responding to eye, hypothalamus/diencephalon, and cor-
tex identities) identified by Pearson correlation analysisuthors
Figure 4. Cultures Treated with Activin or SAG Display Eye or Hypothalamic/Diencephalic Gene Expression Profiles, Respectively
(A) Clustering analysis, showing the distribution of Pearson correlation among transcriptome subsets of different cell cultures and em-
bryonic brain regions. The subset of transcriptome analyzed consists of the 414 gene with the highest variance among cell cultures or
tissues (top 2%; see the Experimental Procedures). Hyp/Die, hypothalamus/diencephalon; SAG, SHH agonist; Rax+ and Rax, K/l EB5 cells
positive or negative for GFP expression, respectively; Wi, Wnt inhibition; Ctx, cortex; Act, Activin.
(B) PCA of samples as in (A). PC1 and PC2 indicate the first and second principal component, respectively, with percentages of explained
variance in parentheses.
(C) Color heatmap showing log2 mean normalized expression of selected gene subsets, marking retina (RET), epiblast (EPI), or endo-
mesoderm (E/M) cell identity in Activin-treated Rax+ and Rax cells.
(D) Color heatmap showing log2 mean normalized expression of selected gene subsets in SAG-treated Rax
+ and Rax cells. Each gene subset
marks a specific prethalamic (purple and dark brown) or hypothalamic (other colors) region, as described in Shimogori et al. (2010).
(E) Color heatmap showing the log2 fold change (FC) ratio of the mean normalized expression values in (D). SMM, supramamillary nucleus;
MM, mamillary nucleus; PM, premamillary region; VMH, ventromedial hypothalamic nucleus; ARC arcuate nucleus; ID, intrahypothalamic
diagonal region; TT, tuberomamillary terminal region; PVN, paraventricular nucleus; EmThal, eminentia thalami; PTh, prethalamus; vAH,
ventral anterior hypothalamus. Tissue samples were obtained from n = 3 embryos (wild-type, Sv129s6 mouse strain, Taconic) and pooled
together before RNA extraction. In vitro samples were produced with n = 3 technical replicates; cells were dissociated and pooled together
before processing.
See also Figure S6.(Figure 4B). Unexpectedly, neither analysis was able to
neatly separate Rax+ from Rax cells in cultures treated
with Activin or SAG. A closer inspection of each transcrip-
tome contributed to explaining why Rax+ and Rax cells
seemed more homogeneous than expected when
compared to embryonic tissues. In cultures treated with
Activin, Rax cells expressed higher levels of both epiblast
and endo/mesoderm markers in comparison to Rax+ cells
but also appreciable levels of retinal markers, including
Rax. This suggests that a fraction of these cells had activated
Rax expression and started retinal differentiation, even ifStem Cellthey had not yet accumulated enough GFP fluorescence,
and that the ratio of GFP-positive cells at DIV 10 represents
an underestimation of the fraction of cells with a retinal
gene expression profile. In cultures treated with SAG,
both Rax+ and Rax cells expressed a substantial number
of hypothalamic and prethalamic markers (Figure 4C and
data not shown). We then extrapolated small subsets of
markers that identify distinct hypothalamic and/or pretha-
lamic regions, as previously described (Shimogori et al.,
2010; Figure 4C; Figure S6H). This analysis indicated
that Rax+ cells preferentially express markers of ventralReports j Vol. 5 j 532–545 j October 13, 2015 j ª2015 The Authors 539
Figure 5. Terminal Differentiation of Activin-Treated Cells or
SAG-Treated Cells Generates Rhodopsin-Positive Neurons or
Gad65-Positive Neurons, Respectively
(A) Scheme of long-term mESC differentiation in the presence of
Wnti and Activin (Wnti/Act), with or without Cyc, or with Wnti and
SAG (Wnti/SAG). Activin and SAG were applied 12 hr after the start
of Wnti treatments, whereas Cyc was delivered simultaneously
with Wnti.
(B) qRT-PCR of retinal marker (Rax, Crx, Vsx2) expression 18 DIV.
Results are normalized to samples with maximal expression levels
for each marker. Error bars were obtained from the error propaga-
tion formula (n = 3 independent experiments).
(C–F) Representative images of K/l EB5 cells differentiated in the
indicated conditions at 22 DIV. Rhodopsin-positive cells are indi-
cated by arrowheads in (E). Gad65-positive neurons (27.6% GAD65-
positive cells among B-III-Tub-positive neurons) are indicated by
arrowheads in (F). The boxed area in (D) is shown at higher
magnification in (E). The scale bars represent 30 mm (C and D),
10 mm (E), and 15 mm (F).
See also Figure S7.
540 Stem Cell Reports j Vol. 5 j 532–545 j October 13, 2015 j ª2015 The Ahypothalamic regions, whereas Rax cells tend to express
markers of more dorsal hypothalamic regions or prethala-
mic areas (Figure 4D), in agreement with the distribution
of Rax expression in the developing hypothalamus and
diencephalon (Wataya et al., 2008).
Our results suggest that both Activin and SHH signaling
are able to drive Rax expression in early anterior neural pro-
genitors, but that they work independently of each other
promoting alternative cell fates. Different from SHH
signaling, Activin supports formation of retinal progenitors
coexpressing Rax and PAX6, rather than Rax-NKX2.1-posi-
tive ventral hypothalamic progenitors. To further support
these conclusions, we evaluated the ability of Rax+ progen-
itors induced by Activin or SAG treatments to undertake a
retinal neuron differentiation program in long-term cul-
tures (up to 22 DIV; Figure 5A). Besides Rax, cells treated
with Wnti and Activin (10 ng/ml, 12-hr delayed treat-
ment), but not SAG, transcribed Crx, a marker of immature
photoreceptor cells, Vsx2, a marker of differentiating bipo-
lar cells, and Brn3b, a marker of differentiating retinal gan-
glion cells, at 18–22 DIV (Figure 5B; Figure S7F). At 22 DIV,
cells positive for Rhodopsin, a marker of more mature pho-
toreceptors, were evident in these cultures (Figures 5D and
5E) but not in control or SAG-treated cultures (data not
shown). Rhodopsin-positive cells were preferentially
located in close proximity to clusters of Rax-GFP-positive
retinal progenitors, but they showed weak Rax-GFP signal
themselves (Figures 5D and 5E). This is consistent with
the fact that retinal progenitors switch off Rax expression
when they undergo terminal differentiation (Furukawa
et al., 1997a, 1997b). In contrast, SAG-treated long-
term cultures produced GAD65-positive neurons (27.6%;
Figure 5F). At 22 DIV, cells treated with both Wnti and
Activin also upregulated other markers of retinal neuron
differentiation in comparison with Wnti-treated samples.
In addition to Rhodopsin, Cone Opsin (cones), BRN3
(ganglion cells), VSX2 (bipolar cells), and Recoverin
(pan-photoreceptor) were detected in significant percent-
ages of cells (Figures S7A–S7E and S7G). These results
suggest that Rax-expressing progenitors generated in the
presence of Activinmainly acquire a retinal identity, which
can be distinguished from SHH-dependent hypothalamic
fates.
Activin Promotes Eye Field Gene Expression in
Differentiating hESCs
Culture of hESCs as floating aggregates in a chemically
defined minimal medium (CDMM) (Vallier et al., 2004) is
permissive, to some extent, for differentiation to neural
progenitors expressing early anterior neural markers
such as OTX2 and PAX6 (Patani et al., 2009; Smith et al.,
2008; Vallier et al., 2004). We therefore used this straight-
forward experimental system to address whether Activinuthors
Figure 6. Activin Promotes Eye Field Gene Expression in
Differentiating hESCs
(A) In situ hybridization on floating aggregates obtained following
a 12-day differentiation of hESCs in nonadherent conditions either
in plain CDMM or in the presence of Activin, as indicated. Arrow-
heads point to RAX-positive or VSX2-positive aggregates. Bar his-
tograms show the percentage of aggregates displaying strong (dark
purple), weak (light blue), or absent (white) signal. The scale bars
represent 0.8 mm. Error bars represent SEM. (At least 100 aggre-
gates for each culture condition and probe from one representative
experiment were used for these analyses.) hEBs, human embryoid
bodies.
(B) qRT-PCR of gene expression in hESCs differentiated as floating
aggregates for 12–14 days with or without Activin. Results are
shown as the mean ratio between Activin and control conditions.
Error bars represent SEM. *p < 0.05; **p < 0.01; ns, nonsignificant
(pR 0.05) according to Student’s t test performed between Activin
and control conditions (n = 8 independent experiments).
Stem Celltreatments could promote eye field gene expression in
differentiating hESCs. hESCs were differentiated as floating
aggregates for 12–14 days in basic CDMM or CDMM sup-
plemented with 50 ng/ml Activin. These doses of Activin
were chosen to compensate for limited diffusion of exoge-
nous growth factors within hESC aggregates, as previously
described (Vallier et al., 2004). Cell aggregates were then
harvested for molecular marker analyses by in situ hybrid-
ization and qRT-PCR. As detected by in situ hybridization,
Activin treatments increased the number of OCT4-positive
aggregates, although the majority of the aggregates were
OCT4 negative (Figure 6A). Thus, Activin could delay, but
not prevent, hESC differentiation in these conditions.
Nonetheless, compared with controls, Activin-treated cul-
tures showed stronger expression of eye field markers
(OTX2, RAX, VSX2, PAX6), but not of the telencephalic
marker FOXG1, both in terms of percentage of positive ag-
gregates and staining intensity (Figure 6A). qRT-PCR anal-
ysis confirmed a significant increase in transcription levels
of several eye fieldmarkers (RAX,VSX2, SIX6,OTX2, LHX2,
PAX6) following Activin treatments, whereas telencephalic
markers (OTX1, FOXG1) were not significantly affected
(Figure 6B). These data suggest that Activin can support
the expression of eye field genes during differentiation of
both mESCs and hESCs.DISCUSSION
The extracellular signals that induce the EFTF network in
retinal progenitors are poorly understood. Although inhi-
bition of BMP andWnt/b-catenin signaling has been impli-
cated in eye field formation (Cavodeassi et al., 2005; Lan
et al., 2009), transient downregulation of these pathways
appears to be a prerequisite for the initial specification of
the entire secondary prosencephalon. How the telenceph-
alon, eye field, and hypothalamus are then diversified
within this prosencephalic tissue remains unclear.
In ESC in vitro systems, culture conditions devoid of
exogenous signals or supplemented with inhibitors of
endogenous signals were not sufficient for efficient genera-
tion of retinal progenitors and they drove instead hypotha-
lamic or telencephalic specification (Bertacchi et al., 2015;
Lupo et al., 2013; Nicoleau et al., 2013;Wataya et al., 2008).
To date, efficient acquisition of retinal identity has been
achieved via poorly defined exogenous cues, including
complex extracellular matrices (ECMs) and biological sup-
plements (Lupo et al., 2014; Viczian, 2013; Boucherie et al.,
2013; Eiraku et al., 2011; Gonzalez-Cordero et al., 2013;
Zhu et al., 2013)
Previous work suggested that Activin/Nodal signaling
promotes eye field fates in ESCs. In particular, supplemen-
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increased the production of retinal progenitors from
mESCs (Ikeda et al., 2005). Subsequently, a combination
of the Nodal and ECM molecules entactin and laminin
was found to mimic retinal progenitor induction by
Matrigel (Eiraku et al., 2011). Finally, inhibitors of the
Activin/Nodal pathway repressed eye field gene expression
during neuroectoderm differentiation of hESCs (Lupo
et al., 2013). These studies, however, did not clarify the
role of Activin/Nodal signaling in retinal progenitor
specification.
In this study, we show that Activin promotes eye field
fates in mESCs differentiating to anterior neuroectoderm
in chemically defined minimal media. Activin effectively
upregulated eye field gene expression only when delivered
at moderate doses and within a narrow 24-hr time window
during early steps of neuroectoderm differentiation. In
agreement with previous literature (Lupo et al., 2014;
Smith et al., 2008; Vallier et al., 2004), treatments at higher
doses and/or earlier time points promoted pluripotency
and mesendoderm differentiation and repressed neuroec-
toderm differentiation, whereas later treatments could
not support retinal identity. Moreover, Activin efficiently
enhanced eye field specification only in cultures treated
with inhibitors of Wnt/b-catenin signaling, which pro-
mote anterior neural fates at the expense of posterior fates
in differentiating ESCs (Bertacchi et al., 2013; Lupo et al.,
2013, 2014; Nicoleau et al., 2013). Hence, the effects of Ac-
tivin are dependent on the competence of the responding
cells: we speculate that Activin can upregulate eye field
genes in primitive forebrain progenitors, but not in plurip-
otent cells, later forebrain progenitors, or posterior neural
progenitors. We observed Activin-dependent upregulation
of eye field genes in either adherent or floating aggregate
cultures. Activin enhanced eye field gene expression also
in hESCs differentiating as floating aggregates in chemi-
cally defined medium devoid of ECM components and
serum replacement, indicating that the ability of Activin
to promote eye field fates is not limited to mouse ESCs or
to a specific cell line or culture method.
In mouse embryos, both the developing retina and the
ventral hypothalamus show strong Rax expression (Ikeda
et al., 2005; Wataya et al., 2008; Wilson and Houart,
2004). Consistent with previous studies (Ikeda et al.,
2005;Wataya et al., 2008), we confirmed that SHH agonists
upregulated Rax in mESCs but in the context of ventral hy-
pothalamic specification, becauseRax-expressing cells were
positive for NKX2.1 and negative for PAX6. Upon terminal
differentiation, these cultures generated GAD65-positive
neurons. Side-by-side comparison of Activin and SAG treat-
ments confirmed that the effects of these molecules were
clearly distinguishable. Activin, but not SAG, supported
specification of Rax-PAX6-positive retinal progenitors,
which were endowed with transcriptomic profiles clus-542 Stem Cell Reports j Vol. 5 j 532–545 j October 13, 2015 j ª2015 The Atering with those of embryonic eye tissue and were capable
of undertaking retinal neuron differentiation in long-term
cultures.
Activin/Nodal signaling controls early vertebrate devel-
opment at multiple levels, and it is difficult to distinguish
direct roles in eye development from indirect effects. Fore-
brain and eye formation are affected in fish and mouse
mutants with defective Activin/Nodal signaling (Lu and
Robertson, 2004; Varlet et al., 1997; Wilson and Houart,
2004), but these effects are likely due to the disruption of
mesendodermal signaling centers required for rostral neu-
roectoderm formation (Wilson and Houart, 2004). Exces-
sive Activin/Nodal signaling, however, can repress anterior
neural fates by maintaining pluripotency and/or promot-
ing mesendoderm differentiation within the ectoderm
(Thisse et al., 2000; Vallier et al., 2004). Anterior neural in-
duction occurs prematurely in the epiblast of Nodalmouse
mutants (Camus et al., 2006), but although telencephalic
genes are upregulated in Nodal-deficient anterior neuroec-
toderm, eye field markers (Six3 and Pax6) are not properly
expressed (Camus et al., 2006). Furthermore, during eye
morphogenesis, eye field cells migrating laterally to form
the optic vesicles become exposed to Activin-like signals
released by extraocular tissues. Although these signals are
involved in retinal pigment epithelium and anterior eye
segment specification (Fuhrmann et al., 2000; Ittner
et al., 2005), they might also support retinal progenitor
identity. Highlighting the complex functions of Activin/
Nodal signaling in eye development, recent studies in Xen-
opus found opposite effects of Nodal signaling inhibition
on the specification of retinal identity using different
experimental assays (Messina et al., 2015; Wong et al.,
2015). Clearly, the roles of Activin/Nodal signaling in eye
formation are much more difficult to dissect in vivo than
they are in vitro, and further investigations in animal
model organisms are warranted.
The results described in this and previous studies using
ESC in vitro systems (Bertacchi et al., 2013, 2015; Lupo
et al., 2013, 2014) lead to a model of the role of the
Activin/Nodal pathway in the specification of retinal iden-
tity (Figure 7). In this model, downregulation of Activin/
Nodal signaling in pluripotent cells leads to the emergence
of early anterior neural progenitors, which can acquire
rostral forebrain fates (corresponding to progenitors of
the secondary prosencephalon in vivo) or caudal forebrain
fates (corresponding to progenitors of the diencephalic/
mesencephalic regions in vivo) depending on the levels
of Wnt/b-catenin signaling, as previously described (Lupo
et al., 2014 and references therein). Without further
signaling, primitive rostral forebrain progenitors spontane-
ously evolve toward a default cortical identity (Bertacchi
et al., 2013; Lupo et al., 2014), whereas they can be steered
to retinal fates under the influence of Activin. As inuthors
Figure 7. Model of the Roles of the Activin/Nodal, Wnt/b-Catenin, and SHH Signaling Pathways in the Induction of Rostral
Forebrain Precursors
Embryonic structures and stages of mouse development in vivo corresponding to the progressively more fate-restricted progenitors
emerging during ESC differentiation in vitro are shown. See text for details.previous studies (Ikeda et al., 2005; Wataya et al., 2008),
SHH signaling instead promotes ventral hypothalamic
fates. Although more work is needed to address the func-
tion of Activin/Nodal signals during early eye development
in vivo, this model provides a framework for future studies
aimed at clarifying the mechanisms of eye field formation
and producing retinal progenitors for basic research or
therapy.EXPERIMENTAL PROCEDURES
Murine ESC lines E14Tg2A (passages 25–38) and K/l EB5 (trans-
genic Rax-GFP ESCs, used with the kind permission of Y. Sasai,
RIKEN Center) and H9 hESCs (WiCell) were cultured as described
(Bertacchi et al., 2013; Lupo et al., 2013). All animal protocols
were reviewed and approved by the Animal Protocol Review Com-
mittee at ITB-CNR of Pisa.
Detailed experimental procedures are available in Supplemental
Information.Stem CellACCESSION NUMBERS
The accession number for the microarray gene expression data re-
ported in this paper is GEO: GSE71830.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures and seven figures and can be found with this article
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FOXH1 binding site (blue peaks) among vertebrates. 
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Figure S2, related to Figure 1. Activin  signaling  activation  and  time  course  of
neuroectoderm differentiation and Rax expression upon Activin treatments of differentiating
mESC cultures.
(A) Scheme  of  Activin,  Wnt  inhibitor  (Wnti)  and  BMP  inhibitor  (BMPi)  treatments  during
neuroectoderm differentiation of mESCs. Arrow indicates the time of analysis of FoxH1 expression
(shown in B).
(B) Real time PCR quantification of  FoxH1  expression at 6 DIV in mESCs differentiated in the
presence of different combinations of Activin (ACT, 10-100 ng/ml), Wnti and BMPi, as indicated.
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Values  are  normalized to  samples  with  maximal  expression  levels.  ACT, Activin.  Ctrl  DMSO
indicates control culture condition in which 0.1% vehicle was added to CDMM medium. Error bars
were obtained from the error  propagation formula.  (n = 3 independent  replicates were pooled
together before RNA extraction).
(C) Scheme of mESC neuroectoderm differentiation in the presence of Wnti and Activin. Cells were
differentiated  as  floating  aggregates  for  2  days  and  then cultured in  adherent  conditions  until
harvesting. Days show the time of mouse ESC differentiation after LIF and serum withdrawal (LIF
withd.).
(D,E) Real time PCR quantification of pluripotency ((D),  Oct4,  FGF5), neuroectoderm ((D), Pax6,
NCAM) and eye field  (E)  markers in cells differentiated in the presence of Wnti and Activin and
harvested at 6 or 8 DIV. Activin-treated cultures show upregulation of neuroectoderm and eye field
markers at 8 DIV, while expression of pluripotency markers is transiently maintained until 6 DIV.
Values are normalized to samples with maximal expression levels in (E) and to the expression in
cells  at  6  DIV  in  (F).  Error  bars  were  obtained  from  the  error  propagation  formula.  (n  =  3
independent replicates were pooled together before RNA extraction).
(F-H) Rax/GFP and PAX6 immunocytodetection at 6 or 8 DIV in K/l EB5 cells treated with Activin
and Wnti, showing that Activin-treated cultures contain considerable numbers of Rax/GFP-positive
and PAX6 positive cells at 8 DIV, but not at 6 DIV. (F,G) show representative images of PAX6 and
Rax/GFP staining at 6 DIV  (F) and 8 DIV  (G), while  (H) reports the quantification of  Rax/GFP-
positive and PAX6-positive cells in these assays. Error bars show the standard error of the mean.
Scale bars, 50 microns.
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Figure S3, Related to Figure 2. Early Activin treatments cause dose-dependent inhibition
of neuroectoderm differentiation and activation of eye field genes.(A) Scheme of treatments
with Activin, Wnt inhibition (Wnti) or BMP inhibition (BMPi) during neuroectoderm differentiation of
mESCs. Starting from 3 DIV, cells were treated with different  combinations of  Wnti,  BMPi and
different doses of Activin (10-100 ng/ml), as indicated, and harvested at 6 DIV for molecular marker
analyses.
(B) Color  heat  map showing the relative expression of  markers of  pluripotency (Oct4,  FGF5),
neuroectoderm differentiation  (Nestin,  Sox2,  Pax6),  mesendoderm differentiation  (Gata4-6,  T),
ventral identity (Shh), or secreted antagonists of TGFb family ligands (Lefty1, Lefty2, Follistatin) at
6  DIV  in  mESCs  treated  with  different  combinations  and  doses  of  Activin,  Wnti  or  BMPi,  as
detected  by  Real  time PCR.  Values  are  normalized  to  minimal  (min.,  0,  red  color  code)  and
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maximal (max.,  1,  blue color  code) expression.  Activin causes dose-dependent  upregulation of
pluripotency and mesendoderm genes and downregulation of  neuroectoderm genes and these
effects are stronger in the absence of Wnti. n = 3 independent replicates were pooled together
before RNA extraction.
(C-K) Representative  images  of  OCT4  and  Musashi  immunocytodetection  at  6  DIV,  after
treatments of differentiating mESCs with moderate (10 ng/ml) or high (100 ng/ml) doses of Activin
in combination with Wnti and/or BMPi, as indicated. Activin causes a dose-dependent increase in
the numbers of OCT4-positive cells and a corresponding decrease in the numbers of Musashi
positive-cells. Scale bars, 50 microns.
(L) Quantification of the percentage of cells positive for PAX6 and OCT4 at 6 DIV following similar
treatments to those described in (A, B) and showed in (C-K), as detected by immunocytodetection.
Error bars indicate the standard error of the mean.
(M) Color heat map showing the relative expression, as detected by real time PCR, of markers of
neural patterning at 8 DIV following treatments of differentiating mESCs with different combinations
and doses of Activin, Wnti or BMPi, as described in SF2. Activin causes more efficient upregulation
of eye field genes (Otx2,  Six3,  Rax,  Six6,  Vsx2,  Tbx3) at moderate doses (10 ng/ml) and in the
presence  of  Wnti,  while  it  represses  expression  of  midbrain  (En1)  and  telencephalic  (FoxG1,
Emx2) markers at all doses. Values are normalized to minimal (min., 0, red) and maximal (max., 1,
blue) expression. n = 3 independent replicates were pooled together before RNA extraction
(N) Real  time  PCR quantification  of  neural  patterning  marker  expression  at  6  DIV  in  control
cultures (control), or in cultures treated with the Activin/Nodal inhibitor SB431542 (Act. i), showing
that Act. i treatments have no effect on the expression of region-specific neural markers. Values
are expressed relatively to ß-Actin expression.
Error bars were obtained from the error propagation formula. (n = 3 independent replicates were
pooled together before RNA extraction).
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Figure S4, Related to Figure 2. Delayed  Activin  treatments  promote  eye  field  fates  at
moderate doses. 
(A) Scheme of treatments of differentiating mESCs with different combinations of Activin, Wnti or
6
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BMPi. Different doses of Activin (10-50 ng/ml) were added with a 12 hr delay with respect to Wnt
and BMP inhibitors. 
(B-M) Representative  images  (B-L) and  quantification  (M) of  OCT4  and  Rax/GFP
immunocytodetection at 8 DIV in  K/l  EB5  cells differentiated in the indicated conditions. In the
presence of  Wnti,  Activin  supports formation of  Rax/GFP-positive cells  at  moderate doses (10
ng/ml) and the maintenance of undifferentiated OCT4-positive cells at higher doses (50 ng/ml).
Scale bars, 50 microns. n = 3 independent biological replicates, followed by acquisition and cell
counting of n = 6 images per experiment.
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Figure S5, Related to Figure 3. Activin  and  SAG  promote  eye  field  and  ventral
hypothalamic fates, respectively.
(A-B) Quantification of Rax/GFP-positive K/l EB5 cells as detected by flow-cytometry analysis at 8
DIV following differentiation in the presence of different combination of Wnti (Wi), Cyc, SAG (1-100
nM) or Activin (Act, 10 ng/ml), as indicated. SAG treatments cause dose-dependent increase in the
percentage of  Rax/GFP-positive cells  (A).  No evident  enhancement of  Rax/GFP expression is
detectable in the presence of both Activin and SAG compared to individual treatments (B). Error
bars represent s.e.m. (n = 2 independent experiments with n = 3 in vitro technical replicates per
experiment; Technical replicates were pooled together and analysed by n = 3 cytometry acquisition
each).
(C-D) Real time PCR quantification of Pax6, Nkx2.1 and Rax expression at 8 DIV in K/l EB5 cells
differentiated in the presence of Wnti (C) or Wnti and Activin (D), with or without different doses of
SAG (10-100 nM). SAG treatments cause Pax6 downregulation and Nkx2.1 and Rax upregulation
both in the absence or in the presence of Activin. Values are normalized to samples with maximal
expression levels. Error bars were obtained from the error propagation formula. (n = 3 independent
replicates were pooled together before RNA extraction).
(E) Scheme of treatments with different combinations of Wnti, Activin and SAG of mESC cultures
differentiated as floating aggregates until 10 DIV.
(F)  Representative  images of  Rax/GFP, CTIP2,  NKX2.1 and PAX6 expression as detected by
immunocytodetection in mESC aggregates cultured until 10 DIV in the indicated conditions. Activin
supports formation of cells expressing Rax/GFP and PAX6, while SAG treatments repress PAX6
and increase Rax and NKX2.1 expression. Lower numbers of cells expressing CTIP2 (a marker of
cortical  differentiation)  are  detectable  in  aggregates  treated  with  Activin  or  SAG compared  to
treatments with Wnti only. Scale bars: 30 microns.
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Figure S6, Related to Figure 4.  Transcriptomic analyses on sorted Rax+ and Rax- cells
from cultures treated with Activin or SAG.
(A,B) Flow-cytometry analysis of K/l EB5 cells treated with Activin or SAG as indicated in Fig. 3A
10
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and sorted at DIV10.
(C-E) Expression levels of Rax (C), Pax6 (D) and Nkx2.1 (E), as evaluated by qRT-PCR in sorted
Rax+ and Rax- cells from cultures treated with Activin or SAG.
(F) Clustering  analysis,  showing  the  distribution  of  Pearson  Correlation  among  the  entire
transcriptomes of different cell cultures and embryonic brain tissues. ActA, Activin A; Ctx, Cortex;
Hyp/Die, Hypothalamus/Diencephalon; Rax+ and Rax-, sorted K/l EB5 cells positive or negative for
GFP expression, respectively; SAG, SHH Agonist; Wi, Wnt inhibition .
(G) PCA of  samples  as  in  (F).  PC1 and  PC2 indicate  first  and  second  principal  component,
respectively. 
(H) Subsets of markers that identify distinct hypothalamic and/or prethalamic regions, as previously
described (Shimogori et al., 2010).  SMM, supramamillary nucleus; MM, mamillary nucleus; PM,
premamillary  region;  VMH,  ventromedial  hypothalamic  nucleus;  ARC  arcuate  nucleus;  ID,
intrahypothalamic  diagonal  region;  TT,  tuberomamillary  terminal  region;  PVN,  paraventricular
nucleus; Em Thal, eminentia thalami; PTh, prethalamus; vAH,ventral anterior hypothalamus.
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Figure S7, Related to Figure 5. Activin treatments lead to the expression of markers of
retinal neuronal cell types in long-term cultures.(A,E) Representative images of K/l EB5 cells
differentiated in the indicated conditions and immunostained for both Vsx2 and GFP (A-B), Cone
Opsin and GFP (C), BRN3 and NeuN (D), Rhodopsin and Recoverin (E) at 22 DIV. Arrowheads in
(B,C)  point  to GFP-negative cells  that  express Vsx2 or Cone Opsin,  respectively. Arrows in C
indicate double-positive GFP/Cone Opsin cells . Scale bars: 10 microns.
(F) Induction of  retinal  ganglion cell  (Brn3b),  bipolar  cell  (Vsx2),  photoreceptor  (Crx)  or  retinal
progenitor  (Rax)  markers,  as detected at  22 DIV by  Real  time RT-PCR quantification  in  cells
treated with Wnti/activin compared to cell  treated with Wnti.  Retinal differentiation markers are
upregulated in Activin-treated cultures compared to the Wnti-only condition.  After 8 DIV, culture
medium was supplemented with 2% Fetal Bovine Serum (Ser) to support cell survival. Error bars
were obtained from the error propagation formula. n = 3 in vitro technical replicates were pooled
together before RNA extraction. (G) Ratios of different cell types in Wnti/Activin/serum-treated cells
at DIV22. Error bars show the standard error of the mean. (n = 2 independent experiments).
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SUPPLEMENTAL EXPERIMENTAL PROCEDURES
Mouse embryonic stem cell culture
Murine ES cell lines E14Tg2A (passages 25-38) and K/l-EB5 (transgenic Rax-GFP ES cells, used
with the kind permission of Y. Sasai, Riken Center, Japan) were cultured on gelatin-coated tissue
culture  dishes  at  a  density  of  40,000  cells/cm2.  ES  cell  medium,  which  was  changed  daily,
contained GMEM (Sigma), 10% Fetal Calf Serum, 2mM Glutamine, 1mM sodium Pyruvate, 1mM
non-essential amino acids, 0.05mM β-mercaptoethanol, 100 U/ml Penicillin/Streptomycin and 1000
U/ml recombinant mouse LIF (Invitrogen).
Chemically  defined  minimal  medium  (CDMM)  for  neural  induction  consisted  of  DMEM/F12
(Invitrogen), 2mM Glutamine, 1mM sodium Pyruvate, 0.1mM non-essential amino acids, 0.05mM
β-mercaptoethanol,  100 U/ml Penicillin/Streptomycin supplemented with N2/B27 (no vitamin A;
Invitrogen). The protocol of ES neuralization consisted of two steps. In Step-I, dissociated ES cells
were washed with DMEM/F12, aggregated in agar-coated culture dishes (65,000 cells per cm2)
and cultured as floating aggregates in CDMM for 2 days. The second day, 75% of CDMM was
renewed. In Step-II, ES cell aggregates were dissociated and cultured in adhesion (65,000 cells
per cm2) on Poly-ornithine (Sigma; 20 μg/ml in sterile water, 24 hours coating at 37°C) and natural
mouse Laminin (Invitrogen; 2.5 μg/ml in PBS, 24 hours coating at 37°C) for 4/6 days, changing
CDMM daily. Serum employed for Trypsin inactivation was carefully removed by several washes in
DMEM/F12. To investigate the expression of late markers, Step-II was prolonged when needed,
until a maximum of 22 days, without any additional dissociation/replating; for late term cultures,
50% of the medium was renewed daily, and 2% Fetal Bovine Serum (FBS) was added to colture
medium starting at 8-10 DIV to promote cell survival. For late term retinal differentiation, better
results were obtained when culturing cells  on a glass coated surface,  compared to culture on
plastic plates (data not shown).
Human embryonic stem cell culture
H9  (WiCell  Inc.,  Madison,  Wisconsin,  USA)  hESCs  (55-69  passages)  were  maintained  on
irradiated  mouse  embryonic  fibroblasts  (MEFs)  in  KSR  medium  containing  KO-DMEM
supplemented  with  20%  Serum  Replacement  (Invitrogen),  1  mM  glutamine,  0.1  mM  ß-
mercaptoethanol,  1%  nonessential  aminoacid  stock  and  4  ng/ml  FGF2  following  published
protocols (Schatten, Smith, Navara, Park, & Pedersen, 2005). hESC differentiation was induced by
culture in  floating  aggregate  non-adherent  conditions  in  chemically  defined medium (CDM) as
previously described  (Vallier, Reynolds, & Pedersen, 2004). The composition of CDM was 50%
IMDM (Invitrogen) plus 50% F12 NUT-MIX (Invitrogen), supplemented with 7 µg/ml of Insulin, 15
µg/ml  of  Transferrin,  450  µM  of  monothioglycerol,  1%  chemically-defined  lipid  concentrate
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(Invitrogen) and 5 mg/ml bovine serum albumin fraction V. Floating aggregates were cultured in
plain CDM or in CDM containing 50 ng/ml Activin for 12-14 days, followed by lysis in RLT buffer
(Qiagen) for total RNA purification and real time PCR. Alternatively, cell  aggregates were fixed
overnight  in  4% paraformaldehyde in PBS at  4ºC and stored in  methanol  at  -20ºC for  in  situ
hybridization.  Real  time PCR and  in  situ hybridization analyses were performed as previously
described (Lupo et al., 2013; J. R. Smith et al., 2008).
Growth factor and morphogen treatments on mouse ES cells
The following factors were tested by addition during Step-II, as indicated in the text: Dorsomorphin
(BMP signaling  inhibitor;  Sigma-Aldrich  P5499;  5  μM),  Cyclopamine  (SHH  signaling  inhibitor;
Sigma-Aldrich C4116; 5 μM), SAG ( SHH agonist; Santa Cruz Biotechnology sc-212905; from 1 to
100 nM), SB431542 (TGFbeta-signaling inhibitor; Sigma-Aldrich S4317; 10 μM), IWR-1-Endo (Wnt
inhibitor; Calbiochem 681669; 5/10 μM) and Recombinant Human/Mouse/Rat Activin-A (R&D 338-
AC-005; ranging from 10 to 100 ng/ml). 
Semiquantitative real-time PCR 
Total RNA was extracted from mouse ES cell with NucleoSpin RNA II columns (Macherey-Nagel).
ES cells from at least two-three different wells of 24-well plates were always pooled together to
compensate  for  variability  in  cell  seeding.  RNA quantity  and RNA quality  were assessed with
Nanodrop  and  gel  electrophoresis.  For  each  sample,  200/500  ng of  total  RNA were  reverse-
transcribed. Amplified cDNA was quantified using GoTaq qPCR Master Mix (Promega) on Rotor-
Gene 6000 (Corbett). Amplification take-off values were evaluated using the built-in Rotor-Gene
6000 relative  quantitation  analysis  function,  and relative  expression was calculated with  the 2
-ΔΔCt method, normalizing to the housekeeping gene β-Actin. Standard errors were obtained from
the error propagation formula as described in  (Nordgård, Kvaløy, Farmen, & Heikkilä, 2006) and
statistical significance was probed with randomization test, taking advantage of REST Software
(Pfaffl, Horgan, & Dempfle, 2002). Primers used are listed below.
Activin-A sense AGGGCCGAAATGAATGAAC 
Activin-A antisense ACTTCTGCACGCTCCACTAC 
Brn3 sense TCCCTGTCTCCCTCCTTTG 
Brn3 antisense TCTCTTCCTTTCTTCTGGGATTT 
Crx sense ACCAGGCTGTCCCATACTCA
Crx antisense TCGCCCTACGATTCTTGAAC
Ctip2 sense CCCGACCCTGATCTACTCAC 
Ctip2 antisense CTCCTGCTTGGGACAGATGC 
Emx2 sense GGCTAGAGCACGCTTTTGAG
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FGF5 sense GTCAATGGCTCCCACGAA 





FoxH1 sense CGCCACAACCTTTCCTCTAA 











Lefty2 sense CTCAGATGGGGCGCTCATAC 




Nestin antisense GGGGAAGAGAAGGATGTTGG 
Nkx2.1 sense CAATGAGGCTGACGCCCCCG
Nkx2.1 antisense GAAGTGGGTTTCCTGTCTGAGCG
Nodal sense GAGGGCGAGTGTCCTAACC 
Nodal antisense ATGCTCAGTGGCTTGGTCTT 
Oct4 sense TCAGCTTGGGCTAGAGAAGG







SatB2 sense CATGAGCCCTGGTCTTCTCT 
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Six3 sense TCAACAACCCCACCACCACCTACT
Six3 antisense CACCTCTTTTATGCTTTCTGCCCGC
Six6 sense CAAAAACCGCAGACAAAGAGA   
Six6 antisense GTCGCTGGATGTGATGGAG 
Sox2 sense ACTTTTGTCCGAGACCGAGA
Sox2 antisense CTCCGGGAAGCGTGTACTTA
T (Brachyury) sense TACACACCACTGACGCACACGG
T (Brachyury) antisense GCAGCCCCTTCATACATCGGAG
Tbr1 sense CGCCCTCCTCCATCAAATCCATCG
Tbr1 antisense GCAGTTCTTCTCGCAGTCCCGC
Tbx3 sense ACAAGCGGGGTACAGAGATG 
Tbx3 antisense ACCATCCACCGAGAGTTGTG 
Vsx2 sense CCAGTGACCGAAAAATGTCC
Vsx2 antisense ACATCTGGGTAGTGGGCTTC
β-Actin sense AATCGTGCGTGACATCAAAG 
β-Actin antisense AAGGAAGGCTGGAAAAGAGC
Immunocytodetection 
Cells  prepared  for  immunocytodetection  experiments  were  cultured  on  Poly-ornithine/Laminin
coated round glass coverslips. Cells were fixed using 2% paraformaldehyde for 10-15 minutes,
washed twice with PBS, permeabilized using 0.1% Triton X100 in PBS and blocked using 0.5%
BSA in PBS. Primary antibodies used for microscopy included OCT3/4 (1:200; Santa Cruz DBA sc-
5279), Musashi-1 (1:200; Cell Signaling), Nestin (1:200; Millipore MAB353), FOXG1 (1:200; Abcam
ab18259),  CTIP2 (1:400;  Abcam ab28448),  GAD65 (1:500;  Chemicon MAB351),  PAX6 (1:400;
Covance PRB-278P), NKX2.1 (1:400; Abcam ab76013), GFP (rabbit polyclonal, 1:1000, Invitrogen
A6455; or chicken polyclonal, 1:1000, Aves Lab GFP-1020), Rhodopsin (1:1000; Sigma O4886),
Recoverin (1:500; Millipore AB5585), Opsin red/green (1:1000; Millipore AB5405), BRN3a (1:100;
Millipore AB5945), NeuN (1:1000; Millipore MAB377), β-III-Tubulin (1:1000; Covance MRB435P)
and  Vsx2  (1:200;  Exalpha  X1180P).  Primary  antibodies  were  incubated  2  hours  at  room
temperature; cells were then washed three times with PBS (10' each). Alexa Fluor 488 and Alexa
Fluor 568 anti-mouse, anti-rabbit  or anti-chicken IgG conjugates (Molecular Probes A28175, A-
11008,  A-21441,  A-21124,  A-11061  and  A-11041,  1:500)  were  incubated  1  hr  at  RT in  PBS
containing 0.1% Triton X100 and 0.5% BSA for primary antibody detection, followed by three PBS
washes (10' each). Nuclear staining was obtained with DAPI. The same protocol was applied on
sections of embryoid bodies after fixation (2 hours at 4°C in 2% PFA), dehydration (O/N at 4°C in
30% sucrose), inclusion in OCT and cryostat sectioning.
In situ hybridization
Digoxigenin (DIG)-labeled sense and antisense RNA probes were generated for human  OCT4,
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RAX, OTX2, PAX6 and VSX2 plasmids, as described (W. C. Smith & Harland, 1991). In situ whole-
mount hybridization on human embryoid bodies was carried out as described  (Thisse & Thisse,
2008), with few modifications. Briefly, embryoid bodies were rehydrated in PBST series and treated
with Proteinase K (Sigma; 1:2000 dilution in PBST, 20'), then fixed in 4% PFA for 30'. After several
washes in PBST, embryoid bodies were pre-incubated in hybridization solution (HYB; 5x SSC, 50%
Formamide, 50mg/ml torula RNA, 100mg/ml Heparin, 20% Tween-20, 1M Citric acid) for 6 hours at
65°C, then incubated O/N with HYB plus RNA probes (500ng probe in 1 ml HYB solution). The day
after, the samples underwent several washes in HYB, then in 2X SSC and in 0.2X SSC at 65°C,
and finally in PBST at room temperature. Embryoid bodies were then preblocked in MAB plus 2%
blocking reagent (Roche) for 2 hours at room temperature, and incubated O/N at 4°C with anti-DIG
antibody (1:5000; Roche). Signal detection with BMPurple (Roche) was performed according to
manufacturer's instructions; 2 quick washes with Tetramisole (0.5 mg/ml; Sigma) were performed
before staining to reduce background. To fix colors, samples were incubated in 4% PFA for 30' at
room temperature, washed with PBS and stored at 4°C.
Microarray hybridization and data analysis
Tissues (Cortex, Hypothalamus/Diencephalon and Eye) were dissected from n = 3 mouse embryos
(Sv129s6 strain, Taconic) at embryonic day (E)12.5. Cells were detached by trypsinization, washed
and resuspended in  PBS,  2% FBS,  2mM EDTA and kept  on ice.  Rax::GFP+ and  Rax::GFP-
populations were separated on a S3 Cell sorter (Biorad). Total RNA was extracted with NucleoSpin
RNA II columns (Macherey–Nagel). RNA from three different sets of experiments was pooled. RNA
quality was assessed with Agilent Bioanalyzer RNA 6000 Nano kit; 50 ng of RNA were labeled with
LowInput  QuickAmp  Labeling  Kit  One-Color  (Agilent  Technologies),  purified  and  hybridized
overnight  onto  Agilent  SurePrint  G3 Mouse  Gene Expression Array  (8x60K),  according to  the
manufacturer’s instructions. Agilent Microarray scanner G2564C was used for slide acquisition and
spot analysis was performed with Feature Extraction software (Agilent). Data were background-
corrected  and  normalized  between arrays  by  means  of  Bioconductor  package  limma  (Smyth,
2005). Principal component analysis (PCA) and hierarchical clustering were performed both on
whole-gene expression datasets or on the top 2% genes (n=414) displaying the higher variance
among samples.
ChIP-seq data reanalysis
Raw ChIP-seq data were downloaded as SRA files from NCBI Gene Expression Omnibus (GEO,
http://www.ncbi.nlm.nih.gov/geo/),  converted  into  Fastq  files  and  aligned  to  reference  mouse
(GRCh36/mm8) and human (GRCh37/hg19) genomes using Bowtie (Langmead, Trapnell, Pop, &
Salzberg,  2009).  Taking  advantage  of  rsem-bam2wig  program
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(http://deweylab.biostat.wisc.edu/rsem/),  alignments  were  converted  to  Wiggle  Track  Format  in
order to be loaded and visualized as gene plots in UCSC Genome Browser (Kent et al., 2002).
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